Thumbnail

中东和非洲胰岛素输送设备市场 - 按类型(笔、胰岛素泵、胰岛素注射器等)细分 - 增长、趋势、COVID-19 影响和预测(2021 - 2026 年)

Looking to buy the report?

胰岛素输送设备的市场直接依赖于不断增加的糖尿病患者。近年来,中东和非洲地区的糖尿病患病率惊人地增加。在该地区的大多数国家,糖尿病的发病率一直处于历史最高水平,这主要是由于环境和生活方式的改变。这导致该地区的胰岛素销量很高。胰岛素最初被认为是仅用于 1 型患者的治疗方法,但多年来胰岛素也被相当多的 2 型患者用作治疗线。2018 年中东和非洲的胰岛素输送设备市场为 8.1 亿台,预计在预测期内的复合年增长率为 2.79%。

对胰岛素不断增长的需求导致了巨大的研发活动,涉及制造不同类型的无痛胰岛素输送设备,如 CGM 集成胰岛素泵。最初,注射器是胰岛素输送系统的唯一形式,被认为是痛苦的并且不方便用户使用。因此,诺和诺德、赛诺菲等公司都生产了自己的胰岛素笔。这些具有特定的设定剂量,并且被认为不仅使用起来不那么痛苦,而且还减少了胰岛素的浪费。胰岛素笔的高成本是笔市场增长的唯一突出制约因素。

一大群 1 型糖尿病患者是儿童。需要替代现有的痛苦的基于针的递送系统。因此,胰岛素喷射注射器的发明,一种无痛的胰岛素输送系统已经出现。胰岛素喷射注射器在美国、加拿大等发达国家销量很高。这些喷射注射器被认为是胰岛素输送系统的未来。与传统的胰岛素输送方法相比,对产品及其益处缺乏认识是该产品的突出制约因素。  

中东和非洲地区有大量糖尿病患者。因此,该地区胰岛素输送装置的销售额很高。中东和非洲占全球胰岛素输送设备市场份额的近 3.4%。在大部分中东地区,消费者的可支配收入很高。因此,保健品的支出也很高。该地区的消费者对新技术的接受度很高,预计这将在预测期内推动喷射器市场的销售。 

资料来源:魔多情报分析

关键球员

Dexcom、雅培、强生、Ok biotech、美敦力、诺和诺德、Insujet、赛诺菲、礼来。

主要发展:

2018 年 2 月: Dexcom 收购TypeZero Technologies,为自动化胰岛素输送铺平了道路。此次收购让 Dexcom 参与了创建人工胰腺系统的竞赛,而不是简单地提供连续血糖监测设备。

报告范围:

属性

细节

估计的基准年

2017

33.75pt">

审查期

2012-2017

预测期

2018 – 2023

市场代表

2018 年至 2023 年的百万美元收入和复合年增长率

覆盖地区

中东

报告覆盖率

收入预测和市场动态

购买本报告的理由:

  • 研究中东和非洲市场的当前和未来
  • 借助波特五力分析分析市场的各种观点
  • 预计将主导市场的细分市场的详细分析
  • 预计在预测期内增长最快的地区
  • 确定主要市场参与者采用的最新发展和策略
  • 3 个月的分析师支持,以及市场估算表(Excel 格式)

报告定制和好处:

可以自定义此报告以满足所需的要求。请与我们的分析师联系,他们将确保您获得适合您需求的报告。

1. Introduction

                1.1 Scope of Study

                1.2 Market Definition

                1.3 Executive Summary

2. Research Methodology

                2.1 Study Deliverables

                2.2 Study Assumptions

                2.3 Research Phases

3. Market Insights

                3.1 Technology Trends

                3.2 Industry Attractiveness - Porter's Five Forces Analysis

                                3.2.1 Bargaining Power of the Suppliers

                                3.2.2 Bargaining Power of the Consumers

                                3.2.3 Threat of New Entrants

                                3.2.4 Threat of Substitute Products and Services

                                3.2.5 Competitive Rivalry within the Industry

4.  Market Dynamics

                4.1 Drivers

                4.2 Restraints

                4.3 Opportunities

5. Market Indicators

                5.1 Total Diabetes Population

                5.2 Type 1 Diabetes Population

                5.3 Type 2 Diabetes Population

6. Market Segmentation

                6.1 By Product

                                6.1.1 Reusable pens (cartridge)

                                                6.1.1.1 Reusable pens (cartridge), Revenue (2012-2023)

                                                6.1.1.2 Reusable pens (cartridge), Volume (2012-2023)

                                6.1.2 Disposable Pens

                                                6.1.2.1 Disposable Pens, Revenue (2012-2023)

                                                6.1.2.2 Disposable Pens, Volume (2012-2023)

                                6.1.3 Syringes

                                                6.1.3.1 Syringes, Revenue (2012-2023)

                                                6.1.3.2 Syringes, Volume (2012-2023)

                                6.1.4 Jet Injectors

                                                6.1.4.1 Syringes, Revenue (2012-2023)

                                                6.1.4.2 Syringes, Volume (2012-2023)

                                6.1.5 Insulin Pump

                                                6.1.5.1 Insulin Pump Device

                                                                6.1.5.1.1 Insulin Pump Devices, Revenue (2012-2023)

                                                                6.1.5.1.2 Insulin Pump Devices, Volume (2012-2023)

                                                6.1.5.2 Insulin Pump Reservoir

                                                                6.1.5.2.1 Insulin Pump Reservoirs, Revenue(2012-2023)

                                                                6.1.5.2.2 Insulin Pump Reservoirs, Volume(2012-2023)

                                                6.1.5.3 Infusion Set

                                                                6.1.5.3.1 Infusion Sets, Revenue (2012-2023)

                                                                6.1.5.3.2 Infusion Sets, Volume (2012-2023)

7. Geographical Analysis

                7.1Middle East & Africa

                                7.1.1 South Africa

                                                7.1.1.1 South Africa, Revenue (2012-2023)

                                                7.1.1.2 South Africa, Volume (2012-2023)

                                7.1.2 Saudi Arabia

                                                7.1.2.1 Saudi Arabia, Revenue (2012-2023)

                                                7.1.2.2 Saudi Arabia, Volume (2012-2023)

                                7.1.3 Oman

                                                7.1.3.1 Oman, Revenue (2012-2023)

                                                7.1.3.2 Oman, Volume (2012-2023)

                                7.1.4 Egypt

                                                7.1.4.1 Egypt, Revenue (2012-2023)

                                                7.1.4.2 Egypt, Volume (2012-2023)

                                7.1.5 Iran

                                                7.1.5.1 Iran, Revenue (2012-2023)

                                                7.1.5.2 Iran, Volume (2012-2023)

                                7.1.6 Rest of Middle East & Africa

                                                7.1.6.1 Rest of Middle East & Africa, Revenue (2012-2023)

                                                7.1.6.2 Rest of Middle East & Africa, Volume (2012-2023)

8. Company Profiles

                8.1 Becton and Dickenson

                8.2 Medtronic

                8.3 Insulet

                8.4 Roche

                8.5 Animas

                8.6 Tandem

                8.7 Ypsomed

                8.8 Abbott Diabetes Care

                8.9 Johnson & Johnson

                8.10 Novo Nordisk

                8.11 Sanofi

                8.12 Eli Lilly

                8.13 Dexcom

* Each Company Profile include overview, Revenue, Product and services, Swot, Recent Activities and strategic Analysis.

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Looking to customize report?

Email

Message

By submitting, you confirm that you agree to our privacy policy